Shark Tank’s Namita Thapar Shares Emotional Mirza Ghalib Shayari After Emcure IPO’s Robust Listing

Shark Tank fame Namita Thapar shared an emotional note on social media after Emcure Pharmaceuticals had a strong IPO listing. Thapar, who is part of the promoter group and executive director at Emcure, expressed her feelings through a Mirza Ghalib shayari.

Successful IPO Listing

“Emotional morning today. We got listed at NSE. 68 times oversubscribed, listed at 31% price premium but my Mirza Ghalib shayari sums up my feelings… congratulations Team Emcure,” said Thapar.

Analysts’ Recommendations

Emcure Pharmaceuticals’ IPO received a great response, listing with a 31% price premium, and being 68 times oversubscribed. Analysts suggest that the strong listing reflects confidence in the company’s long-term potential and recommend holding the stock for future gains.

“The strong investor response and listing gain show confidence in the company’s future potential. However, the risks in the pharmaceutical industry should be monitored. Investors may hold their positions with a stop loss at 1200,” said Shivani Nyati, Head of Wealth at Swastika Investmart.

About Emcure Pharmaceuticals

Based in Pune, Emcure Pharmaceuticals develops, manufactures, and markets a wide range of pharmaceutical products globally. The company plans to use the IPO proceeds to pay off debt and for general corporate purposes. The global pharmaceutical market is expected to grow at an annual rate of 5.0% to 5.5% between 2023 and 2028, reaching $1,900 billion to $1,950 billion by 2028.

In FY24, Emcure’s revenue grew 11% year-on-year to Rs 6,658 crore from Rs 5,985 crore the previous year. However, the profit after tax decreased by 6% to Rs 527 crore from Rs 562 crore a year earlier.